Published in The New England Journal of Medicine, the case was originally reported in 1996 and has recently resurfaced ...

Adding a monoclonal antibody cocktail to the standard treatment for inoperable liver cancer nearly doubled the amount of time ...

Recent studies highlight breakthroughs in medical treatments. A novel monoclonal antibody cocktail has shown promise in ...

Designed to bridge the disconnect between acute fracture care and long-term osteoporosis management, Fracture Liaison Services (FLS) are specialised programs that ensure patients who experience a ...

Credit Towfiqu Barbhuiya via Unsplash.jpgFracture Liaison Services (FLS) play a critical role in addressing the growing global burden of ...

A new study published in The New England Journal of Medicine revealed that in early postmenopausal women, zoledronate given at baseline and 5 years proved successful in avoiding ...

Infrequent IV infusions of zoledronate significantly reduce fracture risks in postmenopausal women, according to a ...

cheap IV infusions of a bone-strengthening drug. Women 50 to 60 who got two IV infusions of zoledronate (Reclast) within five ...

Early postmenopausal women who receive zoledronate every 5 years have a lower risk for morphometric vertebral fractures than ...

The novel study, just published in the world-leading New England Journal of Medicine, found zoledronate, a bisphosphonate, is ...

A ground-breaking New Zealand trial has discovered a cheap treatment given only once every five to 10 years can prevent ...

For early postmenopausal women, zoledronate administered at baseline and five years is effective for preventing morphometric ...